RecruitingNot ApplicableNCT06776601

Digital Therapy in Self-management of COPD Patients

Digital Therapy in Self-management of Chronic Obstructive Pulmonary Disease Patients:A Prospective, Open-labled, Multicenter Randomized Controlled Clinical Study.


Sponsor

China-Japan Friendship Hospital

Enrollment

600 participants

Start Date

Jul 18, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This project adopts a whole-process digital therapy intervention package composed of an inhalation technique assessment device, an electronic inhalant medication monitoring device and digital software to guide patients use the inhaler correctly personalizedly, record and manage the behavior data of chronic obstructive pulmonary disease (COPD) patients during the use of inhalant medication, and provide personalized reminders and feedback to patients according to the data. The purpose is to analyze whether this digital intervention scheme can reduce the number of acute exacerbations of COPD, improve the management effect of COPD, and reduce the burden of disease by improving the medication compliance of COPD patients.


Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a digital therapy app (a smartphone-based tool) to help people with COPD (chronic obstructive pulmonary disease — a lung condition causing breathing difficulties) better manage their condition day-to-day, using smart inhalers and app-based monitoring. **You may be eligible if...** - You are 40 years or older - You have been diagnosed with COPD - You had at least one serious COPD flare-up in the past year, but have been stable for the last 4 weeks - You are comfortable using a smartphone - You are using inhaled medication that is compatible with the study's monitoring device **You may NOT be eligible if...** - You have unstable heart problems or other serious medical conditions - You had thoracic, abdominal, or eye surgery within the past 3 months - You are pregnant or breastfeeding - You are allergic to ABS (a type of plastic used in the inhaler device) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALFull process digital therapy intervention package

Patients will receive individualized inhalation skills guidance after being tested by inhalation capacity measuring device, and be equipped with electronic inhalation monitoring devices, which can record their medication using data, reminding patients to use the medication on time, and correct their inhalation mistake. They can also check their inhalation record on their mobile phones. Clinicians can check the record every month to assess their adherence.


Locations(1)

China Japan Friendship Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06776601


Related Trials